Targeted Toxin Use: Botox, Xeomin, & Jeuveau
1 Aug 2025 · 1 min

0:45
Short single-speaker YouTube excerpt (Dr. Charles Mok) discussing targeted use of neuromodulators in aesthetic practice. Speaker contrasts product choices by treatment site—using Botox in the frontalis/forehead and Xeomin for glabella and orbicularis/rabicularis regions for precision—and notes Jeuveau (introduced 2019) as a competitively priced alternative with apparently similar spread/precision and limited comparative studies; mentions modest downward pressure on toxin pricing.










